The next-generation heart pump to change patients’ lives and create a new standard of care

Project description

A smart implantable pump for advanced heart failure

Heart failure is a life-threatening condition in which the heart is unable to pump enough blood to meet the needs of the body. For patients with advanced heart failure and who are either too old or not suitable for a heart transplant, implantable left ventricular assist devices (LVADs) have emerged as a new treatment option. The EU-funded Calypso project will bring to market a game-changing LVAD developed by the French CORWAVE company. This new device relies on a unique and patented breakthrough technology, the wave membrane. Unlike current devices, which are continuous-flow rotary pumps, CorWave LVAD is a smart pump producing a physiologic and pulsatile blood flow, to restore a normal life to patients with minimal side effects.

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

CORWAVE

Address

17 Rue De Neuilly Impasse Passoir
92110 Nanterre
France

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 495 675